Lung Carcinoma Staging Problems - 20/08/11
Doi : 10.1016/j.path.2010.03.008
Philip T. Cagle, MD a, b, ⁎ 
a Department of Pathology and Laboratory Medicine, Weil Medical College of Cornell University, 1300 York Avenue, New York, NY 10065, USA
b Department of Pathology, The Methodist Hospital, Main Building, Room 227B, 6565 Fannin Street, Houston, TX 77030, USA
Department of Pathology, The Methodist Hospital, Main Building, Room 227B, 6565 Fannin Street, Houston, TX 77030.Abstract |
The tumor-node-metastasis (TNM) system is the most commonly used staging system for cancers, including lung cancer. The TNM descriptors and the stage groupings reflect differences in patient prognosis and choices for specific therapies. Generally, the higher the T, N, or M, and the higher the stage grouping, the worse the prognosis is for patients in that category. TNM stage is traditionally the most important factor predicting survival of lung cancer patients.
Le texte complet de cet article est disponible en PDF.Keywords : Lung, Carcinoma, Staging, Tumor-node-metastasis, TNM system
Plan
© 2010
Elsevier Inc. Tous droits réservés.
Vol 3 - N° 1
P. 61-69 - mars 2010 Retour au numéro
Article précédent
- Pulmonary Neuroendocrine Tumors
- Leslie A. Litzky
- Targeted Therapies in Lung Cancer
- Lucian R. Chirieac, Sanja Dacic
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?